Finance Times Gazette
SEE OTHER BRANDS

Your finance and banking news reporter

Finance Times Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Finance Times Gazette.

Press releases published on April 28, 2025

AGF Investments Extends Termination Date of AGF Emerging Markets Bond Fund

AGF Investments Extends Termination Date of AGF Emerging Markets Bond Fund

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- AGF Investments is extending the termination date of AGF Emerging Markets Bond Fund (the “Fund”) to on or about May 26, 2025 (the “Fund Termination Date”) in order to facilitate an orderly wind down of the Fund. …

Brown & Brown, Inc. announces first quarter 2025 results, including total revenues of $1.4 billion, an increase of 11.6%; Organic Revenue growth of 6.5%; diluted net income per share of $1.15; Diluted Net Income Per Share - Adjusted of $1.29; and a…

Brown & Brown, Inc. announces first quarter 2025 results, including total revenues of $1.4 billion, an increase of 11.6%; Organic Revenue growth of 6.5%; diluted net income per share of $1.15; Diluted Net Income Per Share - Adjusted of $1.29; and a…

DAYTONA BEACH, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- Brown …

Honeygain Partners with Tipalti to Enhance Global Payout Experience

Honeygain Partners with Tipalti to Enhance Global Payout Experience

Honeygain partners with Tipalti to streamline global payouts, making it easier for users to earn by sharing their internet connection. LONDON, UNITED KINGDOM, April 28, 2025 /⁨EINPresswire.com⁩/ -- Honeygain, the first-ever app that allows its users to …

Report on Financial Results for the Year Ended December 31, 2024

Report on Financial Results for the Year Ended December 31, 2024

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Mitchell Cohen, Chief Executive Officer and President of Urbanfund Corp. (TSX-V: UFC) (“Urbanfund” or the “Company”), confirmed today that the Company has filed its financial statements for the year ended …

Volatus Announces $2,000,000 Financing

Volatus Announces $2,000,000 Financing

Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”) is pleased to …

Volatus annonce un financement de 2 000 000 $

Volatus annonce un financement de 2 000 000 $

Interdiction de diffusion aux agences de presse américaines et de diffusion aux États-Unis. TORONTO, 28 avr. 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV : FLT) (OTCQX : TAKOF) (Francfort : ABB) (« Volatus » ou la « Société ») a le plaisir d' …

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …

GROUNDBREAKING NON-INVASIVE THERAPY 
TREATING FIRST RESPONDERS AND VETERANS, 
SCORES BIG WITH PROFESSIONAL ATHLETES

GROUNDBREAKING NON-INVASIVE THERAPY 
TREATING FIRST RESPONDERS AND VETERANS, 
SCORES BIG WITH PROFESSIONAL ATHLETES

VECTTOR™ Technology, a groundbreaking non-invasive therapy designed to treat chronic pain and neurological disorders, is scoring big with professional athletes. WIMBERLEY, TX, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- VECTTOR™ Technology, a …

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …

Trident Filed 2024 Annual Report on Form 20-F

Trident Filed 2024 Annual Report on Form 20-F

SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today …

RBB Bancorp Reports First Quarter 2025 Earnings

RBB Bancorp Reports First Quarter 2025 Earnings

LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- RBB Bancorp (NASDAQ:RBB) and its subsidiaries, Royal Business Bank (the “Bank”) and RBB Asset Management Company (“RAM”), collectively referred to herein as the “Company,” announced financial results for the …

 Macerich Declares the Quarterly Dividend on Its Common Shares

Macerich Declares the Quarterly Dividend on Its Common Shares

SANTA MONICA, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on June 17, 2025, to stockholders of record …

iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates

iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates

- Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25 - Interim datasets from GALAXIES H…

Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to Follow

Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to Follow

SAN RAFAEL, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business …

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today unveils …

Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance

Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance

GIG HARBOR, Wash., April 28, 2025 (GLOBE NEWSWIRE) -- Heritage Distilling Holding Company, Inc. (“HDC” or “Heritage” or the “Company”) (Nasdaq: CASK), a leading craft distiller of innovative premium brands, today reported it regained compliance with the …

SAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024

SAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- SAIHEAT Limited (“SAIHEAT” or the “Company”) (NASDAQ: SAIH), today reported audited financial results for the fiscal year ended December 31, 2024. Financial Highlights for the Year Ended December 31, 2024 Total …

Terra Balcanica annonce un placement fondé sur la dispense pour financement de l’émetteur coté

Terra Balcanica annonce un placement fondé sur la dispense pour financement de l’émetteur coté

NE PAS DIFFUSER AUX ÉTATS-UNIS OU PAR L’INTERMÉDIAIRE DES SERVICES D’INFORMATION DES ÉTATS-UNIS Vancouver, Colombie-Britannique, 28 avr. 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (« Terra » ou la « Société ») (CSE : TERA; FRA : UB1) a le …

Intellomx Launches Swarm-Based AI Platform to Accelerate and De-Risk Novel Target and Drug Discovery

Intellomx Launches Swarm-Based AI Platform to Accelerate and De-Risk Novel Target and Drug Discovery

Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic target identification capability. CAMBRIDGE, UNITED KINGDOM, April 28, 2025 /⁨EINPresswire.com⁩/ -- Intellomx (Intelligent OMICS Ltd) …

Portillo’s Announces Plan to Further Strengthen Board Through Cooperation Agreement with Engaged Capital

Portillo’s Announces Plan to Further Strengthen Board Through Cooperation Agreement with Engaged Capital

CHICAGO, April 28, 2025 (GLOBE NEWSWIRE) -- Portillo’s Inc. (“Portillo’s” or the “Company”) (NASDAQ: PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, today announced that it has entered into a cooperation agreement …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service